EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hematocrit-adjusted tacrolimus levels are associated with acute kidney injury but not rejection early after liver transplantation

Trana Hussaini, Daljeet Chahal, Vladimir Marquez, Tianyi Wen, Monica Dahiya, Eric M Yoshida, Michael R Law

Frontiers in Transplantation · 03.07.2026 · 5

DOI: 10.3389/frtra.2026.1878595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Transplantation, online erschienen am 03.07.2026. Verfasst von Trana Hussaini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Tacrolimus (Tac) is highly bound to erythrocytes, with less than 1% present in the pharmacologically active unbound fraction. In anemia, whole-blood trough concentrations may underestimate effective exposure. Hematocrit (Hct) adjustment has been proposed but clinical outcome data are limited.

Methods

We conducted a single-center retrospective cohort study of adult liver transplant recipients (2018 to 2022) to examine the relationship between Hct-adjusted Tac and early clinical outcomes. Tac troughs, Hct, and serum creatinine were collected for 90 days. Hct-adjusted Tac was calculated as (0.45 ÷ Hct) × total Tac. The difference between adjusted and measured Tac (delta Tac) was used to represent anemia-related underestimation and modeled as a time-varying covariate in Cox regression for acute kidney injury (AKI) and biopsy-proven T cell-mediated rejection (TCMR), adjusting for established risk factors.

Results

Among 344 recipients (median age 59 years; 62% male), TCMR occurred in 15.7% and AKI in 69.8%. Delta Tac was not associated with TCMR (HR 0.93, 95% CI 0.77 to 1.14) but was associated with higher AKI hazard (HR 1.15 per ng/mL, 95% CI 1.08 to 1.24).

Discussion

These findings suggest that divergence between Hct-adjusted and measured Tac is associated with increased AKI risk without a corresponding signal for rejection.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurydrug monitoringhematocritimmunosuppressionliver transplantationrejectiontacrolimus

Autor:innen und Institutionen

  • Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Division of Gastroenterology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Gastroenterology and Hepatology Research Program, Vancouver, BC, Canada.
  • Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Centre for Health Policy, O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.

Zitieren

APA

Hussaini, T., Chahal, D., Marquez, V., Wen, T., Dahiya, M., Yoshida, E. M., & Law, M. R. (2026). Hematocrit-adjusted tacrolimus levels are associated with acute kidney injury but not rejection early after liver transplantation. Frontiers in Transplantation, 5. https://doi.org/10.3389/frtra.2026.1878595

Vancouver

Hussaini T, Chahal D, Marquez V, Wen T, Dahiya M, Yoshida EM, et al. Hematocrit-adjusted tacrolimus levels are associated with acute kidney injury but not rejection early after liver transplantation. Frontiers in Transplantation. 2026;5. doi:10.3389/frtra.2026.1878595

BibTeX
@article{Hussaini2026,
  author = {Hussaini, Trana and Chahal, Daljeet and Marquez, Vladimir and Wen, Tianyi and Dahiya, Monica and Yoshida, Eric M and Law, Michael R},
  title = {Hematocrit-adjusted tacrolimus levels are associated with acute kidney injury but not rejection early after liver transplantation},
  journal = {Frontiers in Transplantation},
  year = {2026},
  volume = {5},
  doi = {10.3389/frtra.2026.1878595}
}
Kostenlos starten →